ENLI publishes Nordic Q&A on the rules on advertising aimed at healthcare professionals
17 February 2021
Together with the other Nordic countries, ENLI has prepared a Nordic Q&A on the rules on advertising aimed at healthcare professionals. The published Q&A provides answers to specific questions on these rules and supplements the Nordic Compliance Overview. Its purpose being to compare rules and practices in this area in Scandinavia and to make Nordic compliance easier for pharmaceutical companies.
In recent years, ENLI has worked with the other Nordic countries to continuously publish a Nordic Compliance Overview reviewing select topics on advertising aimed at healthcare professionals and comparing the rules of the Nordic countries on this.
ENLI and the other Nordic countries' work has now resulted in a Nordic Q&A on the advertising rules to supplement the recently published Nordic Compliance Overview. The published Q&A contains specific questions on these rules, and each country has provided its replies to these questions. The intention is to compare the rules and practices in this area in Scandinavia and to make Nordic compliance easier for pharmaceutical companies.
The Nordic Q&A will be updated continuously.
You can read the Nordic Compliance Overview here.
You can read the Nordic Q&A here.
ENLI and the other Nordic countries' work has now resulted in a Nordic Q&A on the advertising rules to supplement the recently published Nordic Compliance Overview. The published Q&A contains specific questions on these rules, and each country has provided its replies to these questions. The intention is to compare the rules and practices in this area in Scandinavia and to make Nordic compliance easier for pharmaceutical companies.
The Nordic Q&A will be updated continuously.
You can read the Nordic Compliance Overview here.
You can read the Nordic Q&A here.
